Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Dermatologic 1

Conditions

Squamous Intraepithelial Lesions 1Skin Neoplasms 1Carcinoma, Squamous Cell 1

Interventions

pembrolizumab 12Cisplatin 7Cetuximab 7Carboplatin 7Docetaxel 6Blood Specimen Collection 4Radiotherapy, Intensity-Modulated 3Paclitaxel 3toripalimab 2atezolizumab 2Radiotherapy 2Nivolumab 2Magnetic Resonance Spectroscopy 2Fluorouracil 2Drug Therapy 2tocilizumab 1regorafenib 1osimertinib 1lenvatinib 1fludarabine 1ficlatuzumab 1cemiplimab 1calcipotriene 1bintrafusp alfa protein, human 1avelumab 1alpha-2'-deoxythioguanosine 1aldesleukin 1aflibercept 1Watchful Waiting 1Vinorelbine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Carcinoma, Squamous Cell × Red Light × Clear all
NCT06577311 2024-08-29

Evaluating the Use of Photodynamic Therapy to Treat Facial Cutaneous Squamous Cell Carcinoma in Situ (SCCis)

The Center for Clinical and Cosmetic Research

Phase 2 Recruiting
20 enrolled
DermatologicGynecologic

Squamous Intraepithelial Lesions, Carcinoma, Squamous Cell, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡